$Carisma Therapeutics(CARM.US$
BTIG analyst Justin Zelin maintains$Carisma Therapeutics (CARM.US) $Buy rating and maintain target price of $6.
According to TipRanks data, the analyst's overall win rate in the past year was 36.7%, and the overall average return was 8.2%
BTIG analyst Justin Zelin maintains$Carisma Therapeutics (CARM.US) $Buy rating and maintain target price of $6.
According to TipRanks data, the analyst's overall win rate in the past year was 36.7%, and the overall average return was 8.2%
Translated